This AACR–Novocure grant supports basic and translational cancer research focused on Tumor Treating Fields (TTFields). Priority is given to projects advancing in‑vitro findings into in‑vivo systems, combination therapies, or clinical translation, and all proposals must incorporate use of the Inovitro® system.
Eligibility Criteria:
Applicants must:
- Hold a doctoral degree (PhD, MD, MD/PhD, or equivalent)
- Be an independent investigator (not a postdoctoral or clinical research fellow)
- Be an AACR Active member in good standing
- Have no prior AACR–Novocure grant funding
- Be eligible regardless of citizenship or country of residence
Funding Details:
- $350,000 total funding
- 3‑year grant term
- Project start date: December 1, 2026
Deadline:
- Full application due: June 4, 2026 at 1:00 PM ET
Where to go for further information:
- Program details.
- Contact: grants@aacr.org